HF
LABU icon

HRT Financial’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

HRT Financial’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,180
Closed -$1.19M – 4829
2026
Q1 		$1.19M Buy
+7,180
New +$1.18M ﹤0.01% 1961
2025
Q2 		– Sell
-4,930
Closed -$300K – 3145
2025
Q1 		$300K Sell
4,930
-13,391
-73% -$1.14M ﹤0.01% 1777
2024
Q4 		$1.65M Buy
+18,321
New +$2.16M 0.01% 824
2024
Q3 		– Sell
-63,762
Closed -$7.23M – 2807
2024
Q2 		$7.23M Buy
+63,762
New +$6.83M 0.04% 297
2023
Q4 		– Sell
-25,490
Closed -$1.94M – 2730
2023
Q3 		$1.94M Buy
+25,490
New +$2.62M 0.02% 630
2023
Q1 		– Sell
-43,951
Closed -$6.21M – 2859
2022
Q4 		$6.21M Buy
+43,951
New +$6.13M 0.09% 208
2022
Q3 		– Sell
-20,307
Closed -$2.74M – 3189
2022
Q2 		$2.74M Buy
+20,307
New +$3.46M 0.03% 456
2021
Q4 		– Sell
-6,454
Closed -$7.14M – 3659
2021
Q3 		$7.14M Buy
6,454
+6,075
+1,603% +$7.47M 0.04% 228
2021
Q2 		$557K Sell
379
-1,687
-82% -$2.34M 0.01% 1657
2021
Q1 		$3.26M Sell
2,066
-559
-21% -$1.31M 0.03% 392
2020
Q4 		$5.27M Sell
2,625
-2,919
-53% -$4.65M 0.11% 148
2020
Q3 		$5.94M Buy
5,544
+4,387
+379% +$5.03M 0.17% 95
2020
Q2 		$1.37M Sell
1,157
-567
-33% -$492K 0.04% 441
2020
Q1 		$777K Sell
1,724
-1,392
-45% -$1.27M 0.05% 304
2019
Q4 		$3.58M Buy
+3,116
New +$2.8M 0.15% 112
2019
Q1 		– Sell
-310
Closed -$203K – 667
2018
Q4 		$203K Buy
+310
New +$325K 0.03% 483

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

HRT Financial's LABU Position: Q2 2026 in Review

HRT Financial sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026, closing a stake of 7,180 shares — an estimated $1.19M sold.

HRT Financial first reported a position in LABU in Q4 2018 and held it in 16 quarters. The position peaked at $7.23M in Q2 2024. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • HRT Financial reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 7,180 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $1.19M.
  • HRT Financial first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and held it in 16 quarters.
  • HRT Financial's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $7.23M in Q2 2024.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.